chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed a progressive symmetrical arthritis.  Diagnosed Rheumatoid Arthritis in September 2007.  Symptoms began probably in Spring.  Treatment is ongoing.  8/18/2008 PCP recs received with vax rec.  Seen for WCC 1/29/07 with normal exam, no concerns. RTO 6/6/07 with c/o rash x 4wks. Light brown rash of circular lesions noted on upper back, chest. ? skin infection tx with Loprox. HPV #2 given. 10/10/2008 Rheumatology consult records received with DX: Rheumatoid Arthritis. Seen 10/15/07 with c/o joint pain and swelling, morning stiffness and decreased ROM mainly in the fingers, toes and hands with (+) RF and CCP.  PE (+) for joint swelling and tenderness, DTRs +1 in upper extremities.  Having difficulty with Ultimate Frisbee and climbing bunk bed. Return visit 11/16/07 with increased # of joints affected.  PE (+) for significant synovitis, knees now affected. Seen 3/27/08 with neck pain, likely muscular and mild hair loss. Tx: Plaquenil, Mtx, and TNF inhibitors with some relief.
Information has been received from a health professional concerning a 7 year old female who on 12Mar98 was vaccinated with a dose of varicella virus vaccine live. On 23Feb2004 the pt presented to the physician and was diagnosed with shingles. No product quality complaint was involved. Two other pts were vaccinated with varicella virus vaccine live and developed chickenpox. Additional information has been requested.  Follow up information previously submitted on 05/14/2005 information has been received from a health professional concerning a 7 year old female with no allergies or medical conditions who on 03/12/1998 was vaccinated SC in the right leg with a first dose of varicella virus vaccine live Lot 624724/1127E. There was no illness at the time of vaccination. Follow up information from a health professional indicated that the patient was diagnosed with shingles which bagan on 02/24/2004. The patient complained of pain and an elevated temperature and had exposure to chicken pox 2-3 weeks prior to the illness. Diagnosis was made by clinical signs and symptoms. No diagnostic test were performed. The patient fully recovered approximately 2 weeks after the illness began. Two other patients (WAES0403USA00668 and WAES0403USA00669) were vaccinated with varicella virus vaccine live (lot 24724/1327E) and developed chicken pox. Additional information is not expected.
Initially - expected sore arm .. went away day 7 ..  Day 2: 1/2 my face went numb like I received dental work ? it lasted 3 hr .. went away but not completely? still have some facile tingling on the right side and numbness .. on day 13 / 14 body ache - fatigues - just tired ?  Had covid test on 4/12 - negative  On 4/13 extremities feeling cold - chest feeling ice cold ... fatigue and muscle pain - neurologists facial symptoms of tingling  4/16 was schedule for my 2nd vaccine shot but they told me to hold off another wk bc of my symptoms...  so that Friday and now today I?m just exhausted - body aches - muscle pain - joint pain ? burning neurological pain in my extremities and just muscle pains in large groups ...
High fever, swelling of hands and feet within 48 hours of shot. Possible serum sickness. Blood culture showed meningococcemia (group B). Pt received Steroids and Ceftriaxone. Discharge Summary received on 2/8/2005 states rash.
Pt. with gradual onset of cough since first dose of Moderan Covid vaccine, Pt dx with bronchitis on05/05/2021 was started on cefdinir and inhaler, pt returned on 05/07/2021 was administered albuterol nebulized and a dose of rocephin 50mg  as well as an injection of Methylprednisolone 40 mg due to patient experiencing worsening cough and wheezing.
HEADACHE; FEVER; BODY ACHE; TONGUE SOURED; MOUTH SOURED; This spontaneous report received from a patient concerned a  female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown; expiry: Unknown) dose was not reported, administered on 13-MAR-2021 14:00 for prophylactic vaccination. the batch number was not reported hence requested.No concomitant medications were reported.  On 14-MAR-2021 07:00, the subject experienced mouth soured. On an unspecified date, the subject experienced headache, fever, body ache, and tongue soured. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, body ache, fever, mouth soured and tongue soured was not reported. This report was non-serious.
I was supposed to get my period a couple days prior to getting the covid vaccine. My period never came and now I'm 26 days late. I've taken three urine pregnancy tests and they have come back negative. I'm supposed to get my period once again around the time I'm supposed to get my second covid vaccine. So I'm wondering if the covid vaccine could have  an effect on my menstruation.
2/8/2023 I started having a general achy feeling, my head was pounding and just did not feel quite right. By the end of the evening, I was starting to feel achier and more feverish. I had a slight temperature, under 100 degrees. I took an at home COVID test and it was positive. The next morning, I called my doctor and had a telehealth appointment a few hours later. We talked about PAXLOVID; she suggested I take it. I began taking PAXLOVID that day. Later that day, I was feeling great. The only effects I had, was a bad taste. I finished my PAXLOVID and felt good.
Headache, severe fatigue, severe myalgia, severe arthralgia, chills, excessive sweating, fever 101.4°, excessive thirst, nausea, trouble waking, excessive sleeping, loss of appetite.
I started hurting with just my arm really bad, than, later like at  5pm I started feeling more sick like a headache than at 7:30pm I started with chills hot, like a fever and body ache and really bad all night like when I was sick from Covid-19. I had Covid in January 13th 2021,  and came negative in January 31st 2021. I still feel very sick I have been with a headache all day and right now I feel nauseas, and today is 4-18-2021 and its 11:42 pm I also have a big headache.  I started taking Tylenol 500mg and I'm still taking Tylenol 500mg and Advil 200mg
Muscle pain in back and shoulders, difficulty breathing, numbness in hands, no appetite, blood in urine, flu symptoms - symptoms lasted up to 2-3 weeks after vaccine.
Information has been received from a registered nurse concerning a 60 year old female patient with cancer, on chemotherapy, allergy to DILAUDID and penicillin, and a history of thymectomy, "9 months ago", who on 03-FEB-2011 was vaccinated with a first dose of MMR II. There was no concomitant medication. The nurse reported that the patient developed nausea, vomiting, diarrhea a rash on her face and neck with joint pain and swollen lymph nodes. The nausea diarrhea and vomiting occurred on 12-FEB-2011 and 13-FEB-2011 and then resolved. The patient then developed a rash on her face and neck with joint pain and swollen lymph nodes on 14-FEB-2011. The rash was described as measles like rash. The rash started on the face and neck and proceeded down her body and now was a generalized rash. The patient had no previous vaccination history with MMR II, but was determined to have immunity to mumps and measles, but no immunity to German measles with an unspecified screening test. The patient sought unspecified medical attention. It was reported that on 18-FEB-2011 the patient was treated with ALLEGRA and MOTRIN. At the time of the report, the patient had not recovered from rash on her face and neck with joint pain, swollen lymph nodes and generalized rash. Additional information has been requested.
Patient was diagnosed with an acute pharyngitis on 7/18/11 and given amoxicillin. She had rapid strep done 7/26/11 which was positive and treated with AUGMENTIN. We gave her a Tdap vaccine (BOOSTRIX) on 7/27/11 as preventive vaccine. Within 48 hours she developed pain in right hip, then right elbow, then left hip. She went to prompt care 8/10/11 and had lab work. She went to ER 8/12/11 due to joint pains. She saw me 8/16/11 and we put her on Prednisone - she took it for about 2 weeks and her symptoms resolved and have not come back.
Welt at site of varicella vaccine. Fever to 105 later that night; facial swelling.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant medications and medical histories reported. On an unknown dates between 02-FEB-2016 and 02-APR-2016, the patients were vaccinated with an improperly stored doses of ZOSTAVAX (lot # L029484 with expiration date 06-NOV-2016, lot # L035505 with expiration date 16-DEC-2016, dose, anatomical location and route of administration were not reported). It was also reported that an improperly stored sterile diluent (lot# K023007 with an expiration date 24-SEP-2017, lot# L017417 with and expiration date 02-FEB-2018, lot # L015432 with expiration date 24-JAN-2018, lot # reported as L03221 with an unspecified expiration date; dose and route of administration were not reported) was used. No adverse events were reported. Temperature was 49.3 Fahrenheit degrees (F) for 48 hours, 31.2 F for 16 hours and 16.5 for 2400 hours. There was no previous temperature excursion and no data logger was involved. This is one of several reports received from the same reporter. Additional information had been requested.
Headaches; Chills; Sweats; Body aches/ Myalgia; Fever; Very uncomfortable; Soreness in right arm; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Soreness in right arm), HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats) and MYALGIA (Body aches/ Myalgia) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K208A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN, CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]), CALCIUM, VITAMIN D [VITAMIN D NOS], UBIDECARENONE (CO Q10) and ZINC for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Soreness in right arm). On an unknown date, the patient experienced HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats), MYALGIA (Body aches/ Myalgia), PYREXIA (Fever) and DISCOMFORT (Very uncomfortable). At the time of the report, PAIN IN EXTREMITY (Soreness in right arm), HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats), MYALGIA (Body aches/ Myalgia), PYREXIA (Fever) and DISCOMFORT (Very uncomfortable) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia (97-99): 100.7 High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Information has been received from a licensed practical nurse concerning a female who was vaccinated with 3 doses  RECOMBIVAX HB as a child. The nurse reported that the patient did not seroconvert. The nurse stated that the child "is now 18 years of age". No adverse events reported. The outcome of the patient's event was unknown. This is an amended report. AE term now was mapped to anti-HBs antibody negative instead of seroconversion test negative. Additional information has been requested.
Redness; warmth; This case was reported by a nurse via call center representative and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site erythema and injection site warmth were unknown.   It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to Shingrix.  Additional case details were provided as follows: The age at vaccination was not reported however captured as adult as per the vaccine indication. The nurse reports giving 20 vaccinations this week.  Out of this lot of Shingrix, one patient received the dose of Shingrix and complained of redness at the site, warm to the touch at the injection site.  The nurse reports no reports of adverse experience prior to this lot . The vaccine shortage was mentioned.  No additional details provided.  The nurse stated that due to workload, she was unable to provide requested data but can supply at a later time. This is 1 of the 4 linked cases, reported by the same reporter.
Patient arrived to observation area with caregiver, at 11:15am, no distress noted. Around 11:30am patient notified observation nurse that he felt dizzy and thought his blood sugar might be low. Patient has type 2 diabetes. Vitals stable: P82, R20, BP 108/76, 02:99% O2 administered via non-rebreather mask 10LPM. After 10 minutes, patient stated he felt better and wanted to take the O2 off. Patient stood up and left building with caregiver, no issues.
5-21-15 pt was bitten by a wild kitten which she caught in her back yard. She went to hospital where she stated she rec'd post exposure rabies Tx and was referred to public health for tetanus vaccine. 5-22-15 pt. stated she received Td at approx 5:00 pm and the following symptoms began at approx. 7:00 pm that same day. Pt c/o "needle poke" sensation in her finger tips and palms of both hands and arms and stiffness in both hands. Also had needle poke sensation in her right side of her face (specifically her right cheek). States that these symptoms come and go, but the stiffness in both hands has been constant. Pt stated the kitten was tested for rabies which showed negative results. Pt rec'd four doses of rabies vaccine at hospital on the following dates: 5-21-15, 5-24-15, 5-28-15, 6-4-15. Pt stated she has received antibiotics and anti-inflammatory medications from either or both the hospital or her PCP. Pt's PCP instructed her to do warm water soaks in the AM, light exercises and to taken an anti-inflammatory of which the pt said she was not taking because she doesn't like to take medications.
A non-serious spontaneous report of facial swelling manifested with upper cheeks swelling, eye swelling, URI and wheezing has been received from a health professional concerning a five-year-old female, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received FLUMIST on 15-Nov-2011. On 15-Nov-2011, three hours later receiving FLUMIST the patient experienced facial swelling in upper cheeks and eyes. Also had wheezing then went to emergency room and was diagnosed with upper respiratory infection. The patient was not hospitalized. The patient was prescribed diphenhydramine, prednisolone, azithromycin and ipratropium bromide & albuterol sulfate. At the time of reporting, the patient was ok with no symptoms. The outcome of events facial swelling manifested with upper cheeks swelling, eye swelling, URI and wheezing was resolved.
Vaccine 8/31/13. 9/26/13 birth of second child. 2 days after vaccine worsening soreness in (L) arm. Sharp pain and numbness at hand and weakness.
At 1636, received vaccine Pfizer 0.3ml IM in left deltoid.  She was sitting in her chair holding her laptop, dropped laptop, staff checked on her. She had her head down, large amount of vomit on the floor, tapped her on the shoulder and was responsive. Asked if she was okay and responded, "Yes and apologetic for vomiting." At 1650, DSH-Napa's dispatch/Fire Department was notified. Her vitals signs were taken T97.0-P92-R20-BP 121/78 O2 sat-97% RA. was unaware she vomited or dropped her laptop.  reports, "sitting in observation area, became flush, lightheaded, then slight tunnel vision, so she closed her eyes and passed out".  Fire department responded, ambulance took her to ER where she was Dx Vasovagal Syncope. She reports receiving IV fluids in ambulance, no further tx at. She reports Hx of near syncopal episode after having a blood drawn recently due to pregnancy. Patient is pregnant and her due date is 11/1/21.
Rash that started at elbow of arm that received shot; rash spread to all of both arms; to upper part of both legs; to stomach and chest area of body.
Vaccine was given 9/30/2022 when by use date on box was 9/29/2022. No adverse events afterwards.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-FEB-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-FEB-2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-FEB-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-FEB-2022) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2022 at 2:13 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Feb-2022 at 2:13 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-FEB-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-FEB-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-FEB-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-FEB-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No concomitant product reported by reporter.  Patient received booster dose on 02-FEB-2022 02:13:03 PM.  The patient received Moderna vaccine past its 30 day of expiry date. Vaccine went into 2-to-8-degree Celsius thaw state on or about 24-Dec-2021. The vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. .  No treatment information was provided.
Happened at urgent care on 01/30/18. Patient received a flu vaccine that morning and stated he started feeling bad immediately. He went back to urgent care and was given a shot in the hip and sent home. He was found dead the next morning with no apparent cause.
no adverse effect; improperly stored PEDVAX HIB were administered/patient received one dose; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 15-APR-2019, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) injection, lot # R027320 with expiration date on 08-JUL-2021 (dose and route of administration were not reported) for prophylaxis. The vaccine underwent the temperature excursion of above 47 (55.4) degrees Fahrenheit for 10 hours 45 minutes and below 36 (34.4) degrees Fahrenheit for 20 minutes. Digital Data Logger was involved in recording of the excursion. No previous temperature excursions were reported. No adverse effects were reported.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-1904USA012614: US-009507513-1904USA012967: US-009507513-1904USA012968: US-009507513-1904USA012969: US-009507513-1904USA012970: US-009507513-1904USA012971: US-009507513-1904USA012972: US-009507513-1904USA012973: US-009507513-1904USA012974: US-009507513-1904USA012975: US-009507513-1904USA012976: US-009507513-1904USA012977: US-009507513-1904USA012979: US-009507513-1904USA01280: US-009507513-1904USA012981:
Red bumps at first very painful and itchy, it got worse the next 3 or so days. Went to Immediate Care and it was diagnosed as shingles. They gave me 2 oral treatments and a cream to help with the symptoms.
1 day after,   prickling feeling under skin, that moves around my body.  kind of makes it itch,  day of vaccine at facility.  Blood pressure got high, flushing in face and chest. general weakness in legs.   That night some nausea,  and a slight headache.   NO fever ever.   Still have prickling feeling and this is day four.
Patient states that her arm has been extremely sore since the time of administration. Her arm is still painful and she has great difficulties raising her arm beyond a 90 degree angle. Patient has been using heat to try and relieve the pain and was advised to follow-up with PCP.
Pain, swelling, redness and heat, cool compresses ordered, Ibuprofen, may take Benadryl, cannot r/o cellulitis.  Antibiotic given but instructed to hold if better.
5/27/99 pt aunt stated red spot on rt leg noticed during bathing child;3PM presented child w/1 1/2 x 1 1/2 area on leg small blister on edge where band aid was;advised to MD given APAP & ATB;
. Pharmacy technician mistakenly used Modena Monovalent vial and administered 0.5ml  to patient as booster. He realized afterwards. No adverse events reported by patient. Patient was at clinic for 15-20 min after injection and no adverse event occurred while she was at the clinic.
Heart palpitations. Heart rate higher than normal for being inactive (sitting, lying down, just standing).
given their second shots 2 WEEKS after their first; This case was reported by a consumer and described the occurrence of drug dose administration interval too short in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The patient was reporter's sister. The age at vaccination was not reported. The patient received second shot two weeks after first shot, which led to shortening of vaccination schedule. The reporter was worried that the patient was not properly immunized and asked advice if the patient should received second shot again. No further information was provided. This case has been linked with case US2021AMR087444, reported by the same reporter for patient's husband.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR087444:same reporter (Male PT case)
Presented in ER with right leg redness (small amount). Mother states baby crying and choking. Temperature is 99.8F. Dx'd with slight local reaction to right leg.